C
Chromocell Therapeutics Corp
AMEX:CHRO
Chromocell Therapeutics Corp
AMEX:CHRO
Price:
22.46
USD
-5.03%
Market Closed
Market Cap:
$3.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Chromocell Therapeutics Corp
AMEX:CHRO
|
US |
|
ICL Group Ltd
NYSE:ICL
|
IL |
|
I
|
ID Holdings Corp
TSE:4709
|
JP |
|
Compagnie Lebon SA
PAR:ALBON
|
FR |
|
Martin Midstream Partners LP
NASDAQ:MMLP
|
US |
|
Deceuninck NV
XBRU:DECB
|
BE |
|
Machvision Inc
TWSE:3563
|
TW |
|
Guangdong Tengen Industrial Group Co Ltd
SZSE:003003
|
CN |
|
A-One Seimitsu Inc
TSE:6156
|
JP |
|
E
|
Elektrocieplownia Bedzin SA
WSE:BDZ
|
PL |
|
OEL (Holdings) Ltd
SGX:584
|
SG |
|
S
|
Sigma Energy Compressindo Tbk PT
IDX:SICO
|
ID |
|
Global Information Inc
TSE:4171
|
JP |
|
Eversource Energy
NYSE:ES
|
US |
Income Statement
Earnings Waterfall
Chromocell Therapeutics Corp
Chromocell Therapeutics Corp
Income Statement
Chromocell Therapeutics Corp
Chromocell Therapeutics Corp
Currency: USD
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(7)
|
(8)
|
(8)
|
(6)
|
(5)
|
|
| Selling, General & Administrative |
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(3)
|
(1)
|
(1)
|
|
| Operating Income |
(1)
N/A
|
(2)
-87%
|
(2)
-27%
|
(3)
-27%
|
(3)
-16%
|
(4)
-7%
|
(7)
-86%
|
(8)
-15%
|
(8)
+0%
|
(6)
+26%
|
(5)
+8%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(2)
-86%
|
(2)
-27%
|
(3)
-27%
|
(4)
-20%
|
(4)
-9%
|
(7)
-81%
|
(9)
-22%
|
(8)
+8%
|
(6)
+25%
|
(6)
+10%
|
|
| Net Income | ||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(7)
|
(9)
|
(8)
|
(6)
|
(6)
|
|
| Net Income (Common) |
(1)
N/A
|
(2)
-86%
|
(2)
-27%
|
(3)
-27%
|
(4)
-20%
|
(4)
-9%
|
(7)
-81%
|
(9)
-22%
|
(8)
+8%
|
(6)
+25%
|
(6)
+10%
|
|
| EPS (Diluted) |
-0.18
N/A
|
-0.34
-89%
|
-0.43
-26%
|
-0.55
-28%
|
-0.66
-20%
|
-0.72
-9%
|
-1.28
-78%
|
-1.91
-49%
|
-1.43
+25%
|
-1.02
+29%
|
-0.91
+11%
|
|
Switch to:
Switch to:
See Also
Discover More
